Evidence map›Paper›PMID 28931678›Full record

ArticleJournal of virology2017

IKKγ-Mimetic Peptides Block the Resistance to Apoptosis Associated with Kaposi's Sarcoma-Associated Herpesvirus Infection.

Louise C Briggs, A W Edith Chan, Christopher A Davis, Nicholas Whitelock, Hajira A Hotiana, Mehdi Baratchian, Claire Bagnéris, David L Selwood, Mary K Collins, Tracey E Barrett

Open access · hybridAbstract read
In one paragraph

Article in Journal of virology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. A structural atlas of death domain fold proteins reveals their versatile roles in biology and function.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  2. Review
  3. Human Gammaherpesvirus 8 Oncogenes Associated with Kaposi's Sarcoma.International journal of molecular sciences · 2022
    Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Kaposi sarcoma.Nature reviews. Disease primers · 2019
    Review
  11. Stapled Peptides Inhibitors: A New Window for Target Drug Discovery.Computational and structural biotechnology journal · 2019
    Review
  12. Role of the NFκB-signaling pathway in cancer.OncoTargets and therapy · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 2 countries.

Louise C BriggsInstitute for Structural and Molecular Biology, Department of Biological Sciences, Birkbeck College, London, United Kingdom.
A W Edith ChanThe Wolfson Institute for Biomedical Research, University College London, London, United Kingdom.
Christopher A DavisMRC-University of Glasgow Centre for Virus Research, Glasgow, Scotland, United Kingdom.
Nicholas WhitelockBiopharmaceutical Bioprocessing Technology Centre, Newcastle University, Newcastle upon Tyne, United Kingdom.
Hajira A HotianaInstitute for Structural and Molecular Biology, Department of Biological Sciences, Birkbeck College, London, United Kingdom.
Mehdi BaratchianThe Medical Research Council Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, London, United Kingdom, and Division of Advanced Therapies, National Institute of Biological Standards and Control, South Mimms, Potters Bar, Herts, United Kingdom.
Claire BagnérisInstitute for Structural and Molecular Biology, Department of Biological Sciences, Birkbeck College, London, United Kingdom.
David L SelwoodThe Wolfson Institute for Biomedical Research, University College London, London, United Kingdom.
Mary K CollinsThe Medical Research Council Centre for Medical Molecular Virology, Division of Infection and Immunity, University College London, London, United Kingdom, and Division of Advanced Therapies, National Institute of Biological Standards and Control, South Mimms, Potters Bar, Herts, United Kingdom.
Tracey E BarrettInstitute for Structural and Molecular Biology, Department of Biological Sciences, Birkbeck College, London, United Kingdom t.barrett@mail.cryst.bbk.ac.uk.
Birkbeck, University of London · GBNational Institute for Biological Standards and Control · GBMRC University of Glasgow Centre for Virus Research · GBNewcastle University · GBUniversity College London · GBWolfson Foundation · GB

Funding

Cancer Research UK C19746/A9867Cancer Research UK C484/A12595Medical Research Council G0701236
6 · The paper itself

Abstract

Primary effusion lymphoma (PEL) is a lymphogenic disorder associated with Kaposi's sarcoma-associated herpesvirus (KSHV) infection. Key to the survival and proliferation of PEL is the canonical NF-κB pathway, which becomes constitutively activated following overexpression of the viral oncoprotein KSHV vFLIP (ks-vFLIP). This arises from its capacity to form a complex with the modulatory subunit of the IκB kinase (IKK) kinase, IKKγ (or NEMO), resulting in the overproduction of proteins that promote cellular survival and prevent apoptosis, both of which are important drivers of tumorigenesis. Using a combination of cell-based and biophysical assays together with structural techniques, we showed that the observed resistance to cell death is largely independent of autophagy or major death receptor signaling pathways and demonstrated that direct targeting of the ks-vFLIP-IKKγ interaction both in cells and

Indexed as

ApoptosisAutophagyEtoposideHerpesvirus 8, HumanHumansI-kappa B KinaseJurkat CellsMolecular MimicryPeptidesProtein BindingSarcoma, KaposiSignal TransductionTumor Necrosis Factor-alphaViral ProteinsEtoposideI-kappa B KinasePeptidesTumor Necrosis Factor-alphaviral FLIP protein, Human herpesvirus 8Viral Proteinsantimicrobial peptidesKaposi's sarcoma-associated herpesvirusvFLIP

Identifiers

PMID28931678
PMCPMC5686756
OpenAlexW2755480343

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.